Literature DB >> 21283959

Dysphagia in adults operated on for esophageal atresia--use of a symptom score to evaluate correlated factors.

V Gatzinsky1, L Jönsson, C Johansson, G Göthberg, U Sillén, L G Friberg.   

Abstract

INTRODUCTION: Dysphagia is not unusual following repair of esophageal atresia (EA). The lack of a uniform definition has led to a variance when it comes to reporting the prevalence of dysphagia among patients operated on for EA. Our aim is to estimate the occurrence and degree of dysphagia, using a numerical score with its statistical versatility independent of a specific definition. The results are used to find early risk factors of dysphagia within this patient group. The results are also used to see whether we can find a correlation between dysphagia and symptoms of gastroesophageal reflux (GER) and quality of life (QoL).
METHODS: 79 consecutive survivors operated on for EA in Gothenburg between 1968 and 1983 were located. Hospital charts were reviewed and patients received questionnaires on dysphagia, symptoms of GER and QoL. Dysphagia was measured by a numerical score, symptoms of GER were extracted using a predetermined questionnaire (GerdQ), and QoL was determined using the generic questionnaire SF-36.
RESULTS: 73 patients (92.4%) returned the questionnaires. In order to make the study group as homogeneous as possible with regard to the malformation we choose to study the 63 patients representing the vast majority: those with Gross type C. 36 patients (57%) had symptoms of dysphagia to varying degrees. We did not find any aggravating factors in their hospital charts nor did we find any correlation to the most recent demographics. There was a significant difference in dysphagia scores when we compared Gross type C to the often more complex type A (p<0.05). We did not find any correlation to heartburn but a strong correlation to regurgitation with an OR of 2.8 (95% CI: 1.2-6.6). The QoL was good for this patient group, and we did not find any correlation between QoL and the dysphagia score.
CONCLUSIONS: The dysphagia score provides easy-to-use results when it comes to evaluating the potential influence of dysphagia. Dysphagia is common within this patient group. Patients operated on for EA Gross type A seem to do worse when it comes to dysphagia. Regurgitation is associated with dysphagia, which could imply that GER is an aggravating factor. Further studies to support this finding will show whether there is a correlation between the dysphagia score and the results of 24-h pH-monitoring. If so, this could mean that treating GER might decrease dysphagia, at least in this patient group. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21283959     DOI: 10.1055/s-0030-1270454

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  5 in total

Review 1.  Health-related quality of life among children, young people and adults with esophageal atresia: a review of the literature and recommendations for future research.

Authors:  Michaela Dellenmark-Blom; John Eric Chaplin; Vladimir Gatzinsky; Linus Jönsson; Kate Abrahamson
Journal:  Qual Life Res       Date:  2015-04-01       Impact factor: 4.147

2.  Long-term respiratory symptoms following oesophageal atresia.

Authors:  Vladimir Gatzinsky; Linus Jönsson; Linda Ekerljung; Lars-Göran Friberg; Göran Wennergren
Journal:  Acta Paediatr       Date:  2011-04-06       Impact factor: 2.299

3.  Pulmonary function in children and adolescents after esophageal atresia repair.

Authors:  Felipe Donoso; Hans Hedenström; Andrei Malinovschi; Helene E Lilja
Journal:  Pediatr Pulmonol       Date:  2019-09-18

4.  Predictors of histopathological esophagitis in infants and adolescents with esophageal atresia within a national follow-up programme.

Authors:  Felipe Donoso; Anna Beckman; Andrei Malinovschi; Helene Engstrand Lilja
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

5.  Dysphagia in children with repaired oesophageal atresia.

Authors:  Catelijne H Coppens; Lenie van den Engel-Hoek; Horst Scharbatke; Sandra A F de Groot; Jos M T Draaisma
Journal:  Eur J Pediatr       Date:  2016-08-20       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.